| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.2B | $7.7B | $7.4B | $6.9B | $7.8B | $2.1B | $2.1B | $2.1B |
| Cost of Revenue | $2.5B | $2.2B | $2.1B | $2.0B | $2.3B | $2.1B | $2.3B | $2.3B |
| Gross Profit | — | — | — | — | — | $1.3B | $1.4B | $1.3B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.3B | $2.9B | $2.8B | $2.8B | $3.3B | $3.2B | $3.3B | $3.4B |
| Operating Income | $1.1B | $1.3B | $1.3B | $0.7B | $0.8B | $-0.1B | $1.1B | $0.0B |
| Net Income | $0.7B | $0.9B | $1.0B | $0.2B | $0.4B | $0.3B | $0.3B | $-0.9B |
| EPS (Basic) | $3.56 | $4.45 | $4.91 | $1.10 | $1.93 | $1.61 | $1.56 | $-4.42 |
| EPS (Diluted) | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 | $1.59 | $1.54 | $-4.42 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $23.1B | $21.4B | $21.5B | $21.1B | $23.5B | $24.4B | $24.6B | $24.1B |
| Current Assets | $5.1B | $4.7B | $4.6B | $4.4B | $4.9B | $5.1B | $4.7B | $4.4B |
| Cash & Equivalents | $0.6B | $0.5B | $0.4B | $0.4B | $0.5B | $0.8B | $0.6B | $0.5B |
| Total Liabilities | $10.4B | $8.9B | $9.0B | $9.0B | $10.8B | $12.2B | $12.2B | $12.9B |
| Current Liabilities | $2.6B | $2.5B | $2.9B | $2.4B | $3.5B | $2.6B | $3.4B | $2.4B |
| Stockholders' Equity | $12.7B | $12.5B | $12.5B | $12.0B | $12.7B | $12.2B | $12.4B | $11.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.7B | — | — | — | $1.5B | $1.2B | $1.6B | $1.7B |
| Investing Cash Flow | $-2.0B | — | — | — | $-0.5B | $-0.6B | $-0.7B | $-0.4B |
| Capital Expenditures | $0.2B | $0.2B | $0.3B | $0.2B | $0.2B | $0.1B | $0.2B | $0.2B |
| Financing Cash Flow | $0.3B | — | — | — | $-1.3B | $-0.4B | $-0.8B | $-1.3B |